Trial Profile
Post-Marketing Surveillance of the Safety, Tolerability and Efficacy of Desloratadine Syrup Among Filipino Pediatric Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Adverse reactions
- Sponsors Organon
- 27 Jan 2012 Trial phase changed from II to III as reported by ClinicalTrials.gov.
- 27 Jan 2012 Actual patient number (2980) added as reported by ClinicalTrials.gov.
- 22 Sep 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.